Immunic, INC Schedule 13G passive stakes

NASDAQ
Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, has disclosed a 1.55% beneficial ownership stake in Immunic, Inc., holding 1,398,600 shares of common stock as of December 31, 2024.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.35% in Immunic Inc as of December 31, 2024.